Safety of Dietary Guanidinoacetic Acid: A Villain of a Good Guy?

Overview

Journal Nutrients

Date 2022 Jan 11

PMID 35010949

Authors

Sergej M Ostojic

Affiliations

Soon will be listed here.

Abstract

Guanidinoacetic acid (GAA) is a natural amino acid derivative that is well-recognized for its central role in the biosynthesis of creatine, an essential compound involved in cellular energy metabolism. GAA (also known as glycocyamine or betacyamine) has been investigated as an energy-boosting dietary supplement in humans for more than 70 years. GAA is suggested to effectively increase low levels of tissue creatine and improve clinical features of cardiometabolic and neurological diseases, with GAA often outcompeting traditional bioenergetics agents in maintaining ATP status during stress. This perhaps happens due to a favorable delivery of GAA through specific membrane transporters (such as SLC6A6 and SLC6A13), previously dismissed as un-targetable carriers by other therapeutics, including creatine. The promising effects of dietary GAA might be countered by side-effects and possible toxicity. Animal studies reported neurotoxic and pro-oxidant effects of GAA accumulation, with exogenous GAA also appearing to increase methylation demand and circulating homocysteine, implying a possible metabolic burden of GAA intervention. This mini-review summarizes GAA toxicity evidence in human nutrition and outlines functional GAA safety through benefit-risk assessment and multi-criteria decision analysis.

Citing Articles

Evaluation of guanidinoacetic acid supplementation on finishing beef steer growth performance, skeletal muscle cellular response, and carcass characteristics.

Eckhardt E, Kim W, Jaborek J, Garmyn A, Kang D, Kim J J Anim Sci. 2024; 102.

PMID: 39487675 PMC: 11633455. DOI: 10.1093/jas/skae337.

Post-marketing surveilance study of creatine-guanidinoacetic acid safety in healthy adults.

Ranisavljev M, Todorovic N, Stajer V, Ostojic S Front Nutr. 2024; 11:1414308.

PMID: 39135558 PMC: 11317414. DOI: 10.3389/fnut.2024.1414308.

Effects of guanidinoacetic acid supplementation on liver and breast muscle fat deposition, lipid levels, and lipid metabolism-related gene expression in ducks.

Wu H, Xie J, Peng W, Ji F, Qian J, Shen Q Front Vet Sci. 2024; 11:1364815.

PMID: 38435369 PMC: 10904544. DOI: 10.3389/fvets.2024.1364815.

Effect of Guanidinoacetic Acid Supplementation on Growth Performance, Rumen Fermentation, Blood Indices, Nutrient Digestion, and Nitrogen Metabolism in Angus Steers.

Yi S, Hu S, Wang J, Abudukelimu A, Wang Y, Li X Animals (Basel). 2024; 14(3).

PMID: 38338043 PMC: 10854538. DOI: 10.3390/ani14030401.

Comparing the metabolic pathways of different clinical phases of bipolar disorder through metabolomics studies.

Guo Q, Jia J, Sun X, Yang H, Ren Y Front Psychiatry. 2024; 14:1319870.

PMID: 38264633 PMC: 10804847. DOI: 10.3389/fpsyt.2023.1319870.

References

Ostojic S . Short-term GAA loading: Responders versus nonresponders analysis. Food Sci Nutr. 2020; 8(8):4446-4448. PMC: 7455984. DOI: 10.1002/fsn3.1744. View

Ostojic S, Stojanovic M, Hoffman J . Six-Week Oral Guanidinoacetic Acid Administration Improves Muscular Performance in Healthy Volunteers. J Investig Med. 2015; 63(8):942-6. DOI: 10.1097/JIM.0000000000000212. View

Kharbanda K, Todero S, Thomes P, Orlicky D, Osna N, French S . Increased methylation demand exacerbates ethanol-induced liver injury. Exp Mol Pathol. 2014; 97(1):49-56. DOI: 10.1016/j.yexmp.2014.05.006. View

Semeredi S, Stajer V, Ostojic J, Vranes M, Ostojic S . Guanidinoacetic acid with creatine compared with creatine alone for tissue creatine content, hyperhomocysteinemia, and exercise performance: A randomized, double-blind superiority trial. Nutrition. 2018; 57:162-166. DOI: 10.1016/j.nut.2018.04.009. View

Ostojic S, Stajer V, Ratgeber L, Betlehem J, Acs P . Guanidinoacetic Acid Consumption via Regular Diet in Adults. Ann Nutr Metab. 2021; 78(1):46-47. DOI: 10.1159/000520550. View

Stromberger C, Bodamer O, Stockler-Ipsiroglu S . Clinical characteristics and diagnostic clues in inborn errors of creatine metabolism. J Inherit Metab Dis. 2003; 26(2-3):299-308. DOI: 10.1023/a:1024453704800. View

HIGGINS A, HARPER H, KLINE E, MERRILL R, Jones R, Smith T . Effects of creatine precursors in arthritis; clinical and metabolic study of glycocyamine and betaine. Calif Med. 1952; 77(1):14-8. PMC: 1521637. View

Ostojic S, Ostojic J, Drid P, Vranes M, Jovanov P . Dietary guanidinoacetic acid increases brain creatine levels in healthy men. Nutrition. 2016; 33:149-156. DOI: 10.1016/j.nut.2016.06.001. View

Schug S, Pogatzki-Zahn E, Phillips L, Noyes Essex M, Xia F, Reader A . Multi-Criteria Decision Analysis to Develop an Efficacy-Safety Profile of Parenteral Analgesics Used in the Treatment of Postoperative Pain. J Pain Res. 2020; 13:1969-1977. PMC: 7415456. DOI: 10.2147/JPR.S255921. View

10.

Ostojic S, Stojanovic M . Guanidinoacetic acid loading affects plasma γ-aminobutyric acid in healthy men. Eur J Nutr. 2015; 54(5):855-8. DOI: 10.1007/s00394-015-0858-5. View

11.

Ganguly P, Alam S . Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015; 14:6. PMC: 4326479. DOI: 10.1186/1475-2891-14-6. View

12.

DIXON H, DICKEL H, SHANKLIN J, Peterson R, West E . Therapy in anxiety states and anxiety complicated by depression. West J Surg Obstet Gynecol. 1954; 62(6):338-41. View

13.

Zugno A, Stefanello F, Streck E, Calcagnotto T, Wannmacher C, Wajner M . Inhibition of Na+, K+-ATPase activity in rat striatum by guanidinoacetate. Int J Dev Neurosci. 2003; 21(4):183-9. DOI: 10.1016/s0736-5748(03)00038-8. View

14.

Hanna-El-Daher L, Beard E, Henry H, Tenenbaum L, Braissant O . Mild guanidinoacetate increase under partial guanidinoacetate methyltransferase deficiency strongly affects brain cell development. Neurobiol Dis. 2015; 79:14-27. DOI: 10.1016/j.nbd.2015.03.029. View

15.

LIVERSEDGE L . Glycocyamine and betaine in motor-neurone disease. Lancet. 1956; 271(6953):1136-8. DOI: 10.1016/s0140-6736(56)90154-4. View

16.

Joncquel-Chevalier Curt M, Cheillan D, Briand G, Salomons G, Mention-Mulliez K, Dobbelaere D . Creatine and guanidinoacetate reference values in a French population. Mol Genet Metab. 2013; 110(3):263-7. DOI: 10.1016/j.ymgme.2013.09.005. View

17.

Ostojic S, Todorovic N, Stajer V . Effect of Creatine and Guanidinoacetate Supplementation on Plasma Homocysteine in Metabolically Healthy Men and Women. Ann Nutr Metab. 2021; 77(5):307-308. DOI: 10.1159/000518126. View

18.

Ostojic S, Stojanovic M, Olcina G . Oxidant-Antioxidant Capacity of Dietary Guanidinoacetic Acid. Ann Nutr Metab. 2015; 67(4):243-6. DOI: 10.1159/000441198. View

19.

FALLIS B, LAM R . Betaine and glycocyamine therapy for the chronic residuals of poliomyelitis. J Am Med Assoc. 1952; 150(9):851-3. DOI: 10.1001/jama.1952.03680090015007. View

20.

Ostojic S . Benefits and drawbacks of guanidinoacetic acid as a possible treatment to replenish cerebral creatine in AGAT deficiency. Nutr Neurosci. 2017; 22(5):302-305. DOI: 10.1080/1028415X.2017.1385176. View